Altered gene and protein expression in liver of the obese spontaneously hypertensive/NDmcr-cp rat

Nutrition and Metabolism

Volumn 9, Issue 1, 2012, Pages

  Chang, Jie ^a,b   Oikawa, Shinji ^a   Ichihara, Gaku ^b   Nanpei, Yui ^a   Hotta, Yasuhiro ^a   Yamada, Yoshiji ^a   Tada Oikawa, Saeko ^a   Iwahashi, Hitoshi ^c,e   Kitagawa, Emiko ^c,f   Takeuchi, Ichiro ^d   Yuda, Masao ^a   Ichihara, Sahoko ^a  

^a MIE UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f Applied Science   (Japan)

Author keywords

Liver; Metabolic syndrome; Microarray analysis; Obesity; Pathophysiology; Proteomics analysis

Indexed keywords

ION CHANNEL; MESSENGER RNA; TRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GENE EXPRESSION; ION TRANSPORT; LIPID METABOLISM; LIVER TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; RNA EXTRACTION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

EID: 84866479446     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-87     Document Type: Article

References (38)

1. Fall CH, Borja JB, Osmond C, Richter L, Bhargava SK, Martorell R, Stein AD, Barros FC, Victora CG, COHORTS group: Infant-feeding patterns and cardiovascular risk factors in young adulthood: data from five cohorts in low- and middle-income countries. Int J Epidemiol 2011, 40:47-62.
2. Arnlöv J, Ingelsson E, Sundström J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121:392-400.
3. Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, Negri E, Franceschi S, La Vecchia C: Metabolic syndrome and endometrial cancer risk. Ann Oncol 2011, 22:884-889.
4. Hsieh SD, Muto T, Tsuji H, Arase Y, Murase T: Clustering of other metabolic risk factors in subjects with metabolic syndrome. Metabolism 2010, 59:697-702.
5. Yamada Y, Ichihara S, Kato K, Yoshida T, Yokoi K, Matsuo H, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Lee W, Nozawa Y: Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet 2008, 45:22-28.
6. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2003, 163:427-436.
7. Striffler JS, Bhathena SJ, Michaelis OE 4th, Campbell JD, Hansen CT, Scalbert E, Thibault N, Velasquez MT: Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension. Metabolism 1998, 47:1199-1204.
8. Koletsky S: Obese spontaneously hypertensive rats-a model for study of atherosclerosis. Exp Mol Pathol 1973, 19:53-60.
9. Yamamoto J, Ikena K, Yamori Y: Obese and hypertensive SHR/NDmcr-cp rats - A model of metabolic syndrome. Adiposcience 2005, 2:243-248.
10. Ichihara S, Noda A, Nagata K, Obata K, Xu J, Ichihara G, Oikawa S, Kawanishi S, Yamada Y, Yokota M: Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Cardiovasc Res 2006, 69:726-735.
11. Nishizawa T, Iwase M, Kanazawa H, Ichihara S, Ichihara G, Nagata K, Obata K, Kitaichi K, Yokoi T, Watanabe M, Tsunematsu T, Ishikawa Y, Murohara T, Yokota M: Serial Alteration of β-adrenergic signaling in dilated cardiomyopathic hamsters. Circ J 2004, 68:1051-1060.
12. Kondo T, Hirohashi S: Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 2006, 1:2940-2056.
13. Oikawa S, Yamada T, Minohata T, Kobayashi H, Furukawa A, Tada-Oikawa S, Hiraku Y, Murata M, Kikuchi M, Yamashima T: Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic Biol Med 2009, 46:1472-1477.
14. Furukawa A, Oikawa S, Hasegawa-Ishii S, Chiba Y, Kawamura N, Takei S, Yoshikawa K, Hosokawa M, Kawanishi S, Shimada A: Proteomic analysis of aging brain in SAMP10 mouse: a model of age-related cerebral degeneration. Mech Ageing Dev 2010, 131:379-388.
15. Huang Z, Ichihara S, Oikawa S, Chang J, Zhang L, Takahashi M, Subramanian K, Mohideen SS, Wang Y, Ichihara G: Proteomic analysis of hippocampal proteins of F344 rats exposed to 1-bromopropane. Toxicol Appl Pharmacol 2011, 257:93-101.
16. Iwahashi H, Kitagawa E, Suzuki Y, Ueda Y, Ishizawa YH, Nobumasa H, Kuboki Y, Hosoda H, Iwahashi Y: Evaluation of toxicity of the mycotoxin citrinin using yeast ORF DNA microarray and Oligo DNA microarray. BMC Genomics 2007, 8:95.
17. Iwahashi Y, Kitagawa E, Iwahashi H: Analysis of mechanisms of T-2 toxin toxicity using yeast DNA microarrays. Int J Mol Sci 2008, 9:2585-2600.
18. Relógio A, Schwager C, Richter A, Ansorge W, Valcárcel J: Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Res 2002, 30:e51.
19. Sakakibara Y, Yanagisawa K, Katafuchi J, Ringer DP, Takami Y, Nakayama T, Suiko M, Liu M-C: Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. J Biol Chem 1998, 273:33929-33935
20. Khor VK, Dhir RD, Yin X, Ahima RS, Song W-C: Estrogen sulfotransferase regulates body fat and glucose homeostasis. Am J Physiol Endocrinol Metab 2010, 299:E657-E664.
21. Ahima RS, Stanley TL, Khor VK, Zanni MV, Grinspoon SK: Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in associated with TNF-a and SOCS3. J Clin Endocrinol Metab 2011, 96:E1153-E1158.
22. Freimuth RR, Raftogianis RB, Wood TC, Moon E, Kim U-J, Xu J, Siciliano MJ, Weinshilboum RM: Human sulfotransferases SULT1C1 and SULT1C2: cDNA characterization, gene cloning, and chromosomal localization. Genomics 2000, 65:157-165.
23. Buqué X, Martínez MJ, Cano A, Miquilena-Colina ME, García-Monzón C, Aspichueta P, Ochoa B: A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J Lipid Res 2010, 51:500-513.
24. Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, Scott MS, Gramolini AO, Morris Q, Hallett MT, Rossant J, Hughes TR, Frey B, Emili A: Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125:173-186
25. Hornshøj H, Bendixen E, Conley LN, Andersen PK, Hedegaard J, Panitz F, Bendixen C: Transcriptomic and proteomic profiling of two porcine tissues using high-throughput technologies. BMC Genomics 2009, 10:30
26. Rogers S, Girolami M, Kolch W, Waters KM, Liu T, Thrall B, Wiley HS: Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Bioinformatics 2008, 24:2894-2900.
27. Qiu Y, Marek M: Transcriptional control of the calreticulin gene in health and disease. Int J Biochem Cell Biol 2009, 41:531-538.
28. Ferreira V, Molina MC, Valck C, Rojas A, Aguilar L, Ramírez G, Schwaeble W, Ferreira A: Role of calreticulin from parasites in its interaction with vertebrate hosts. Mol Immun 2004, 40:1279-1291
29. Szabo E, Feng T, Dziak E, Opas M: Cell adhesion and spreading affect adipogenesis from embryonic stem cells. The role of calreticulin. Stem Cells 2009, 27:2092-2102.
30. Lozyk MD, Papp S, Zhang X, Nakamura K, Michalak M, Opas M: Ultrastructural analysis of development of myocardium in calreticulin-deficient mice. BMC Dev Biol 2006, 6:54
31. Bass J, Chiu G, Argon Y, Steiner DF: Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization. J Cell Biol 1998, 141:637-646
32. Jain HT, Many TN, Riahi Y, Kaiser N, Eckel J, Sasson S: Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Cir Res 2005, 97:1001-1008.
33. Jalali S, Aghasi M, Yeganeh B, Mesaeli N: Calreticulin regulates insulin receptor expression and its downstream PI3 Kinase/Akt signalling pathway. Biochim Biophy Acta 2008, 1783:2344-2351
34. Hatahet F, Ruddock LW: Substrate recognition by the protein disulfide isomerases. FEBS J 2007, 274:5223-5234
35. Puig A, Gilbert HF: Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme. J Biol Chem 1994, 269:7764-7771
36. Jessop CE, Chakravarthi S, Garbi N, Hämmerling GJ, Lovell S, Bulleid NJ: ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J 2007, 26:28-40
37. Rutkevich LA, Cohen-Doyle MF, Brockmeier U, Williams DB: Functional relationship between protein disulfide isomerase family members during the oxidative folding of human secretory proteins. Mol Biol Cell 2010, 21:3093-3105.
38. Boden G, Song W, Duan X, Cheung P, Kresge K, Barrero C, Merali S: Infusion of glucose and lipids at physiological rates causes acute endoplasmic reticulum stress in rat liver. Obesity 2011, 19:1366-1373